| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/10/2003 | US20030130261 Central nervous system disorders; psychological disorders; inflammatory bowel disorders |
| 07/10/2003 | US20030130260 Aryl fused azapolycyclic compounds |
| 07/10/2003 | US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents |
| 07/10/2003 | US20030130238 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/10/2003 | US20030130235 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors |
| 07/10/2003 | US20030130208 Preparation of fagopyritols and uses therefor |
| 07/10/2003 | US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/10/2003 | US20030130177 Antilipemic agents |
| 07/10/2003 | US20030130168 Reverse-turn mimetics and methods relating thereto |
| 07/10/2003 | US20030129702 DNA encoding galanin GALR2 receptors and uses thereof |
| 07/10/2003 | US20030129663 Methods and compositions for modulating oxidized ldl transport |
| 07/10/2003 | US20030129294 Hydroquinone-substituted fatty acid for use in foods; lipase inhibitors; peroxisome proliferator activated receptors; antiaging agents |
| 07/10/2003 | US20030129160 Obesity therapy; adjusting interleukin concentration |
| 07/10/2003 | US20030129134 Method of monitoring neuroprotective treatment |
| 07/10/2003 | US20030129129 Prevention, therapy disease; forming tritiated water; calibration |
| 07/10/2003 | CA2503801A1 2-substituted vitamin d derivatives |
| 07/10/2003 | CA2482392A1 Carboxylic acid derivative |
| 07/10/2003 | CA2471635A1 Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 07/10/2003 | CA2471601A1 Highly sensitive and continuous protein-tyrosine-phosphatase (ptpase) test using 6,8 difluoro-4-methyl-umbelliferylphosphate |
| 07/10/2003 | CA2471540A1 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 07/10/2003 | CA2471348A1 Quinazolinone derivative |
| 07/10/2003 | CA2471306A1 Secreted proteins |
| 07/10/2003 | CA2471297A1 Human netrin receptor and uses thereof |
| 07/10/2003 | CA2471217A1 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 07/10/2003 | CA2471049A1 Amide derivatives as gk activators |
| 07/10/2003 | CA2470781A1 Cystine-knot fold protein |
| 07/10/2003 | CA2470666A1 Secreted protein |
| 07/10/2003 | CA2470367A1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 07/10/2003 | CA2469690A1 Beta-amyloid binding factors and inhibitors thereof |
| 07/10/2003 | CA2468619A1 Adiponectin fragments and conjugates |
| 07/10/2003 | CA2458751A1 Compositions and methods for the treatement of immune related diseases |
| 07/10/2003 | CA2457801A1 Streptococcus thermophilus strain and use thereof |
| 07/09/2003 | EP1325910A1 Aliphatic nitrogenous five-membered ring compounds |
| 07/09/2003 | EP1325904A1 Novel aliphatic compounds, process for their preparation and their usage |
| 07/09/2003 | EP1325749A1 Bone metabolism improving agent |
| 07/09/2003 | EP1325745A1 Preventives and remedies for complications of diabetes |
| 07/09/2003 | EP1325743A1 Compositions for improving lipid metabolism |
| 07/09/2003 | EP1325681A1 Composition for promotion of bone growth and maintenance of bone health |
| 07/09/2003 | EP1325122A2 Modulation of the transcription of pro-inflammatory gene products |
| 07/09/2003 | EP1325117A2 Lipid metabolism enzymes |
| 07/09/2003 | EP1325032A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 07/09/2003 | EP1325028A2 New inhibitors of iapp fibril formation and uses thereof |
| 07/09/2003 | EP1325019A1 Antisense modulation of clusterin expression |
| 07/09/2003 | EP1325014A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 07/09/2003 | EP1325008A1 Piperazine derivatives |
| 07/09/2003 | EP1325000A1 A thiazolidinedione derivative and its use as antidiabetic |
| 07/09/2003 | EP1324998A1 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 07/09/2003 | EP1324995A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 07/09/2003 | EP1324992A1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 07/09/2003 | EP1324991A1 Compounds useful in the treatment of inflammatory diseases |
| 07/09/2003 | EP1324990A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 07/09/2003 | EP1324985A1 Inhibitors of prenyl-protein transferase |
| 07/09/2003 | EP1324974A2 Drugs for diabetes |
| 07/09/2003 | EP1324972A1 Dihydroxy open-acid salt of simvastatin |
| 07/09/2003 | EP1324773A2 Use of a ppar delta activator in the treatment of diseases related to no inhibition or tnf inhibition |
| 07/09/2003 | EP1324771A2 Therapeutic antibodies |
| 07/09/2003 | EP1324760A1 Creatine ester pronutrient compounds and formulations |
| 07/09/2003 | EP1324759A2 Nf-g(k)b inhibitors |
| 07/09/2003 | EP1324753A2 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 07/09/2003 | EP1324750A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment |
| 07/09/2003 | EP0988316A4 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 07/09/2003 | EP0912558B1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 07/09/2003 | EP0612242B1 Use of the pure s(+) isomer of fluoxetine for the preparation of a medicament against migraine headache |
| 07/09/2003 | CN1429222A 激酶抑制剂 Kinase inhibitors |
| 07/09/2003 | CN1429209A Disulfide derivatives useful for treating allergic diseases |
| 07/09/2003 | CN1429113A Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 07/09/2003 | CN1429110A Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 07/09/2003 | CN1429108A 磷酸盐运输抑制剂 Phosphate transport inhibitor |
| 07/09/2003 | CN1428336A Nitrogen monoxide synthase inhibitor, its preparation method and application |
| 07/09/2003 | CN1428153A Organic biological preparation for preventing and curing selenium deficiency disease |
| 07/09/2003 | CN1428145A Quinoline derivative as tachykinin NK3 receptor agonist |
| 07/09/2003 | CN1113966C Fermentation method for preparing acabose by osmosis control |
| 07/09/2003 | CN1113881C 8-substituted-1,3,8-triaza-spiro [4.5] decan-4-on derivatives |
| 07/08/2003 | US6590085 Derivatives of monosaccharides as cell adhesion inhibitors |
| 07/08/2003 | US6589991 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 07/08/2003 | US6589978 Therapy for nervous system disorders |
| 07/08/2003 | US6589977 Bisindolylpyrrole derivatives represented by general formula (I) which are useful in inhibiting cell death and expected as being useful as preventives and remedies for the progress of various diseases in the progress and worsening of which cell |
| 07/08/2003 | US6589970 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 07/08/2003 | US6589963 Drug salt thereof show a hypoglycemic action, a blood hypolipidemic action, an insulin resistance-improving action and a PPAR activating action, and are useful as a hypoglycemic agent, a hypolipidemic agent, an insulin |
| 07/08/2003 | US6589959 Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid]calcium salt |
| 07/08/2003 | US6589952 Imidazo[1,2-a]pyrazines for the treatment of neurological disorders |
| 07/08/2003 | US6589947 Treatment or prevention of Syndrome X in an animal, preferably a mammal including a human subject or a companion animal, using a corticotropin releasing factor (CRF) antagonist alone or together with a glucocorticoid receptor antagonist. |
| 07/08/2003 | US6589944 A method of cleaving glycation endproducts or cross-linked proteins in an organism in need thereof, wherein said method comprises administering an effective amount of a compound or pharmaceutically acceptable salt thereof to said organism for |
| 07/08/2003 | US6589935 Insulin receptor tyrosine kinase substrate |
| 07/08/2003 | US6589934 Methods of treatment of non insulin dependent diabetes mellitus, antagonists of the delayed rectifier potassium channel Kv2.1, methods of using and preparing the antagonists and assays for identifying such antagonist |
| 07/08/2003 | US6589767 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 07/08/2003 | US6589748 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample |
| 07/08/2003 | US6589588 For lowering the absorption of cholesterol from the digestive tract; sterol and/or stanol fatty acid ester composition, wherein the fatty acid moiety comprises blend of less 7% saturated fatty acids and more than 50% polyunsaturated |
| 07/08/2003 | US6589552 Microstructure grains; fine particle size |
| 07/08/2003 | CA2285208C Improved method for producing thiazolidinediones, and new thiazolidinediones |
| 07/08/2003 | CA2220281C A phospholipidic composition, method for the production of such a composition and its use |
| 07/08/2003 | CA2213608C Pharmaceutical composition stabilized with a basic agent |
| 07/08/2003 | CA2141203C Amylin muteins |
| 07/08/2003 | CA1341434C Compositions and methods for administering therapeutically active compounds |
| 07/03/2003 | WO2003054190A1 Novel proteins and dnas thereof |
| 07/03/2003 | WO2003054159A2 Modulating insulin receptor signaling through targeting facl |
| 07/03/2003 | WO2003054012A2 Leptin proteins |
| 07/03/2003 | WO2003053997A2 Methods of increasing endogenous erythropoietin (epo) |
| 07/03/2003 | WO2003053977A1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 07/03/2003 | WO2003053974A1 Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |